TAGLN2 and neoplasm: In 85.3% of GC patients, TAGLN2 expression in tumor tissue markedly exceeded that in paired normal counterparts, and high TAGLN2 expression (score ≥ 2) observed more frequently in tumor tissues (68% vs. 8%).